EYE-SYNC
FDA-cleared VR-based eye tracking platform for concussion diagnosis and visual impairment assessment
Device · On PremiseCompany source
Company profile
About SyncThink
NeuroSync is a digital health company that has developed EYE-SYNC, an FDA-cleared virtual reality-based platform for assessing brain health and neurological function through eye movement analysis. The company addresses a critical gap in neuro health diagnostics, where over 83 million Americans suffer from neurological conditions but lack access to validated, objective diagnostic tools. EYE-SYNC leverages proprietary algorithms and artificial intelligence to measure eye tracking synchronization and gaze fixation, providing clinicians with actionable data in less than 60 seconds. The technology has been validated through 15 years of clinical research conducted in collaboration with the US Department of Defense and the Brain Trauma Foundation. In 2021, the FDA cleared EYE-SYNC as an aid to concussion diagnosis, and in 2019 it received FDA Breakthrough Device Designation. The platform serves multiple markets including healthcare providers, biopharma companies conducting CNS trials, sports organizations managing athlete safety, and military organizations optimizing personnel performance. With over 5,000 certified clinicians and more than 405,000 patient assessments completed, NeuroSync's portable, wireless platform can be deployed anywhere from clinical settings to remote facilities. The technology features 0.9 test-retest reliability, HIPAA-compliant cloud storage, exportable results via PDF or API integration, and unlimited usage with no per-test fees. NeuroSync's solution represents the intersection of digital health, AI, and objective neurological data to transform patient care and performance optimization.
Company description SyncThink official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at SyncThink?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- CNS conditions
- Concussion
- Neurological disorders
- Traumatic brain injury
- Visual and vestibular dysfunction
- Visual tracking impairments
Who it serves
- Biopharma companies
- Healthcare providers
- Hospitals
- Military organizations
- Neurology clinics
- Optometry practices
- Physical therapy clinics
- Sports medicine clinics
- Sports organizations
- Universities
Deployment & integration
Hybrid · On Premise deployment with recorded integration context.
Recorded integration context: EMR systems via API, Secure data transfer capabilities.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
FDA clearance as aid to concussion diagnosis (2021); FDA Breakthrough Device Designation (2019); Over 405,000 patient assessments completed; 5,188 certified clinicians
Partnerships
Recorded partners
- Brain Trauma Foundation
- US Department of Defense
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
NeuroSync Platform
Customizable digital health platform incorporating AI and objective measures for brain health and performance
Platform · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
EYE-SYNCK202927 · 510k · Oct 2, 2021
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Assessment completion time
Less than 60 seconds per assessment
Test-retest reliability
0.9 reliability score
Clinical adoption
5,188 certified clinicians
Patient assessments
405,000+ assessments completed
Data collection
1.5+ billion data points collected
Clinical workflow
Improved patient throughput and workflow efficiency
ROI
Organizations achieve ROI while advancing patient care
Center for Vision and Learning
Better diagnosis of concussion and patient education
Great addition for patient care and community education about better concussion diagnosis
Georgia Tech University
Student athlete concussion assessment and care
Viable asset and strategy in care of student athletes, serving as leader in concussion assessment
Kaizen Brain Center
Improved diagnostic accuracy and workflow efficiency
More accurate diagnosis in shorter period of time with objective measurements
Rice University
Holistic concussion management for student-athletes
Solved major part of concussion management previously lacking, enabling more holistic approach to student-athlete care
St. David's Medical Center
Vestibular therapy with objective patient engagement
Patients enjoy objective data and stay engaged session to session watching their numbers improve over time
The Kutcher Clinic for Sports Neurology
Portable and clinically sensitive concussion assessment tool
Easy to administer, portable, and clinically sensitive tool that is important part of clinical practice
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from SyncThink
Recent articles published on SyncThink's official website.
Blog: Taking EYE-SYNC Across the Pond: The CE Mark Significance
Read on SyncThinkBlog: Why Click-and-Mortar is the Future of Healthcare
Read on SyncThinkBlog: Why In Home Care is Healthcare’s Next Big Shift
Read on SyncThinkSyncThink Secures CE Mark for EYE-SYNC Digital Health Platform
Read on SyncThink07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.